Showing results (1181-1190 of 2,709) with videos related to

Sort By:
Pageof 271
Fundamental & Clinical Pharmacology|April 23, 2026
Alogliptin Delays the Healing of Traumatic Oral Ulcers in the Buccal Mucosa of Wistar RatsMaria Imaculada de Queiroz Rodrigues, Joyce Ohana de Lima Martins, Debora de Souza Collares Maia Castelo-Branco, et al.
Fundamental & Clinical Pharmacology|May 5, 2026
Effect of a Single Oral Dose of Dexamphetamine or Zolpidem on Attention and Reaction Time in Healthy MenVeronika Pfoser-Poschacher, Michael Wolf, Michaela Bayerle-Eder, et al.
Fundamental & Clinical Pharmacology|February 23, 2026
Immunomodulatory Effects of Hyoscine Butylbromide on Mammalian MacrophagesBegüm Rana Atalay, Batuhan Yurtseven, Ebru Akbaba, et al.
Fundamental & Clinical Pharmacology|February 24, 2026
Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024Cécile Chevallier, Anne Batisse, Emilie Monzon, et al.
Fundamental & Clinical Pharmacology|January 1, 1989
Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in manB B Ba, A Iliadis, A Durand, et al.
Fundamental & Clinical Pharmacology|December 21, 2016
Severe excessive daytime sleepiness induced by hydroxyureaBruno Revol, Marie Joyeux-Faure, Marie-Victoire Albahary, et al.
Fundamental & Clinical Pharmacology|December 20, 2016
Double-stranded RNA-dependent protein kinase signalling and paradigms of cardiometabolic syndromeJaspreet Kalra, Arti Dhar
Fundamental & Clinical Pharmacology|December 31, 2016
Protocol of GLUcose COntrol Safety and Efficacy in type 2 DIabetes, a NETwork meta-analysis: GLUCOSE DINET protocol-Rational and designGuillaume Grenet, Audrey Lajoinie, Shams Ribault, et al.
Fundamental & Clinical Pharmacology|January 1, 1990
Effect of CRL 41034 on the adrenergic neuroeffector interaction in the canine saphenous veinC Boulanger, N A Flavahan, Z S Katusic, et al.
Fundamental & Clinical Pharmacology|October 13, 2009
The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targetsUlrike Muscha Steckelings, Franziska Rompe, Elena Kaschina, et al.
Pageof 271